omega-n-methylarginine has been researched along with Cardiovascular Diseases in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Demirbas, N; Eryavuz Onmaz, D; Kutlu, R; Onmaz, M; Unlu, A | 1 |
| Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E | 1 |
| Bode-Böger, SM; Emrich, IE; Fliser, D; Heine, GH; Martens-Lobenhoffer, J; Wagenpfeil, S; Zawada, AM | 1 |
| Linz, TH; Lunte, SM | 1 |
| Higa, N; Masuzaki, H; Sata, M; Shimabukuro, M; Ueda, S | 1 |
| Brennan, DM; Cho, L; Hazen, SL; Tang, WH; Wang, Z | 1 |
| Cheng, ZQ; Jacobs, H; Kasian, K; Light, RB; Mink, SN; Santos-Martinez, LE | 1 |
| Atzler, D; Bache, RJ; Böger, RH; Chen, Y; Fassett, J; Guo, H; Hu, X; Lu, Z; Schwedhelm, E; Xu, X; Zhang, P | 1 |
| Cooke, JP; Ghebremariam, YT | 1 |
| Caplin, B; Leiper, J | 1 |
| Adwani, SH; Breukels, O; Maxwell, SR; Waring, WS; Webb, DJ | 1 |
| Leiper, J; Vallance, P | 1 |
| Cockcroft, JR | 1 |
| Thiemermann, C | 1 |
| Connell, JM; Elliott, HL; Petrie, JR; Ueda, S; Webb, DJ | 1 |
| Drexler, H; Heitzer, T; Just, H; Kurz, S; Luoma, J; Münzel, T; Olschewski, M; Ylä-Herttuala, S | 1 |
| Ruetten, H; Thiemermann, C; Vane, JR; Wu, CC | 1 |
| Bergholm, R; Lahdenperä, S; Liu, ML; Mäkimattila, S; Mäntysaari, M; Schlenzka, A; Summanen, P; Syvänne, M; Taskinen, MR; Vakkilainen, J; Yki-Järvinen, H | 1 |
| Arriero, MD; Casado, S; de Frutos, T; Díaz-Recasens, J; Farré, J; García, R; García-Durán, M; García-Gálvez, G; González-Fernández, F; Jiménez, A; López-Farré, A; Montón, M; Rico, L; Sánchez de Miguel, L | 1 |
| Chan, N; Vallance, P | 1 |
| Tiefenbacher, CP | 1 |
| Dart, A; Esler, MD; Fullerton, M; Jennings, G; Komesaroff, PA; Sudhir, K | 1 |
| Creager, MA; Fang, JC; Fukumoto, M; Ganz, P; Hikita, H; Kinlay, S; Selwyn, AP | 1 |
4 review(s) available for omega-n-methylarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
Topics: Amidohydrolases; Animals; Arginine; Binding Sites; Binding, Competitive; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases; Catalytic Domain; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 2012 |
Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Mellitus; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Mice; Models, Biological; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pre-Eclampsia; Pregnancy; Protein-Arginine N-Methyltransferases; Renal Insufficiency | 2004 |
Exploring vascular benefits of endothelium-derived nitric oxide.
Topics: Acetylcholine; Animals; Arteries; Benzopyrans; Blood Flow Velocity; Cardiovascular Diseases; Elasticity; Endothelium, Vascular; Ethanolamines; Forearm; Humans; Nebivolol; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vasodilation | 2005 |
Endothelial function and nitric oxide: clinical relevance.
Topics: Arginine; Cardiovascular Diseases; Coronary Disease; Endothelium, Vascular; Genetic Therapy; Humans; Nitric Oxide; omega-N-Methylarginine; Risk Factors; Sepsis; Vasoconstriction | 2001 |
2 trial(s) available for omega-n-methylarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Hyperuricaemia does not impair cardiovascular function in healthy adults.
Topics: Acetylcholine; Adolescent; Adult; Baroreflex; Blood Pressure; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Hyperuricemia; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Pulse; Uric Acid; Vascular Resistance; Vasodilator Agents | 2004 |
Low-dose estrogen supplementation improves vascular function in hypogonadal men.
Topics: Acetylcholine; Angiotensin II; Blood Pressure; Cardiotonic Agents; Cardiovascular Diseases; Double-Blind Method; Estrogens; Hemodynamics; Humans; Hypogonadism; Lipids; Male; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
17 other study(ies) available for omega-n-methylarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Effect of cigarette smoking on serum methylarginine and α-klotho levels.
Topics: Aging, Premature; Arginine; Cardiovascular Diseases; Cardiovascular System; Cigarette Smoking; Humans; omega-N-Methylarginine | 2023 |
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry | 2017 |
Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Disease Progression; Female; Germany; Humans; Incidence; Male; Middle Aged; omega-N-Methylarginine; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors | 2018 |
Heat-assisted extraction for the determination of methylarginines in serum by CE.
Topics: Arginine; Cardiovascular Diseases; Electrophoresis, Capillary; Hot Temperature; Humans; omega-N-Methylarginine; Solid Phase Extraction | 2013 |
Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men.
Topics: Acetylcholine; Adult; Aged; Cardiovascular Diseases; Endothelium, Vascular; Forearm; Humans; Male; Middle Aged; Myocytes, Smooth Muscle; Nitroprusside; Obesity; omega-N-Methylarginine; Regional Blood Flow; Risk Factors; Vasodilation; Vasodilator Agents | 2016 |
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Creatinine; Female; Humans; Lysine; Male; Metabolomics; Methylation; Middle Aged; Nitric Oxide Synthase; Odds Ratio; omega-N-Methylarginine; Ornithine; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors | 2009 |
Lysozyme, a mediator of sepsis that intrinsically generates hydrogen peroxide to cause cardiovascular dysfunction.
Topics: Animals; Aspergillus niger; Cardiovascular Diseases; Catalase; Dogs; Enzyme Inhibitors; Hydrogen Peroxide; Muramidase; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Oxygen Consumption; Reactive Oxygen Species; Shock, Septic | 2009 |
Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Female; Genotype; Hypertension; Infusion Pumps, Implantable; Male; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenotype; Risk Factors; RNA Interference; Substrate Specificity; Time Factors; Transfection | 2011 |
DDAH says NO to ADMA.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Risk Factors; Substrate Specificity | 2011 |
Drugs which modulate nitric oxide homeostasis are likely to provide therapeutic benefit in cardiovascular disease.
Topics: Animals; Arginine; Cardiovascular Diseases; Homeostasis; Humans; Mice; Nitric Oxide; omega-N-Methylarginine; Rats; Shock, Septic; Vasodilation | 1993 |
Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease.
Topics: Acetylcholine; Adult; Arginine; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Endothelium, Vascular; Humans; Insulin; Insulin Resistance; Male; Nitric Acid; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Plethysmography, Impedance; Vasodilation | 1996 |
Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Arginine; Arteriosclerosis; Autoantibodies; Cardiovascular Diseases; Endothelium, Vascular; Female; Forearm; Humans; Hypercholesterolemia; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Oxidation-Reduction; Phentolamine; Risk Factors; Smoking; Vascular Resistance; Vasodilation; Vasodilator Agents; Vasomotor System | 1996 |
The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
Topics: Animals; Arginine; beta-Aminoethyl Isothiourea; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Enzyme Induction; Enzyme Inhibitors; Kidney Diseases; Lipopolysaccharides; Male; Multiple Organ Failure; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Wistar | 1995 |
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
Topics: Acetylcholine; Antioxidants; Apolipoproteins; beta Carotene; Blood Flow Velocity; Cardiovascular Diseases; Cholesterol; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Reference Values; Risk Factors; Vasodilation; Vitamin A; Vitamin E | 1999 |
Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils.
Topics: Adult; Aged; Cardiovascular Diseases; CD18 Antigens; Cell Adhesion; Enzyme Induction; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hormone Replacement Therapy; Humans; Luteinizing Hormone; Male; Menstrual Cycle; Middle Aged; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Postmenopause; Premenopause; Receptors, Estrogen; Sex Characteristics; Tamoxifen | 1999 |
Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?
Topics: Animals; Arginine; Biopterins; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Vessels; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Histamine; Humans; Hypercholesterolemia; In Vitro Techniques; Infusions, Intra-Arterial; Ionophores; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pteridines; Pterins; Reactive Oxygen Species; Species Specificity; Substance P; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo.
Topics: Adult; Anatomy, Cross-Sectional; Arteries; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Compliance; Elasticity; Endothelium, Vascular; Enzyme Inhibitors; Humans; Male; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; omega-N-Methylarginine; Risk Factors; Stress, Mechanical | 2001 |